REPAMADE V1/0.2 TABLET

Product Description

REPAMADE V1/0.2 TABLET
Composition: Repaglinide 1mg + Voglibose 0.2mg

Unlock effective glycemic control with REPAMADE V1/0.2 TABLET, a powerful combination therapy designed to manage type 2 diabetes mellitus. Combining Repaglinide, a fast-acting insulin secretagogue, with Voglibose, an alpha-glucosidase inhibitor, this formulation works synergistically to reduce postprandial blood glucose spikes and improve overall blood sugar regulation.

Key Benefits:

• Rapid and targeted blood glucose reduction after meals

• Enhances pancreatic insulin secretion and delays carbohydrate absorption

• Supports better glycemic control without excessive risk of hypoglycemia

• Suitable for patients struggling with post-meal hyperglycemia

Usage:
Recommended as an adjunct to diet and exercise in adult type 2 diabetic patients to achieve optimal glycemic control. The tablet should be administered before meals for maximum efficacy.

Why Choose REPAMADE V1/0.2:

• High-quality formulation with precise dosing of Repaglinide and Voglibose

• Manufactured under stringent pharmaceutical standards ensuring safety and efficacy

• Ideal for medical distributors, pharmacies, and bulk buyers seeking trusted anti-diabetic solutions

• Competitive pricing for large-scale procurement